These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 26945895
1. Tropisetron inhibits high glucose-induced calcineurin/NFAT hypertrophic pathway in H9c2 myocardial cells. Asadi F, Razmi A, Dehpour AR, Shafiei M. J Pharm Pharmacol; 2016 Apr; 68(4):485-93. PubMed ID: 26945895 [Abstract] [Full Text] [Related]
2. Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells. Liu CJ, Cheng YC, Lee KW, Hsu HH, Chu CH, Tsai FJ, Tsai CH, Chu CY, Liu JY, Kuo WW, Huang CY. Mol Cell Biochem; 2008 Jun; 313(1-2):167-78. PubMed ID: 18398669 [Abstract] [Full Text] [Related]
5. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades. Dai H, Jia G, Liu X, Liu Z, Wang H. Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447 [Abstract] [Full Text] [Related]
6. Anti-hypertrophic and anti-apoptotic effects of short peptides of potato protein hydrolysate against hyperglycemic condition in cardiomyoblast cells. Marthandam Asokan S, Yang JY, Lin WT. Biomed Pharmacother; 2018 Nov; 107():1667-1673. PubMed ID: 30257384 [Abstract] [Full Text] [Related]
9. Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway. Yoon JJ, Son CO, Kim HY, Han BH, Lee YJ, Lee HS, Kang DG. Molecules; 2020 Dec 24; 26(1):. PubMed ID: 33374365 [Abstract] [Full Text] [Related]
10. Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation. Rajapurohitam V, Izaddoustdar F, Martinez-Abundis E, Karmazyn M. Cell Signal; 2012 Dec 24; 24(12):2283-90. PubMed ID: 22917533 [Abstract] [Full Text] [Related]
14. Ubiquitin-protein ligase E3a (UBE3A) as a new biomarker of cardiac hypertrophy in cell models. Cheng KC, Li Y, Chang WT, Chen ZC, Cheng JT, Tsai CC. J Food Drug Anal; 2019 Jan 24; 27(1):355-364. PubMed ID: 30648591 [Abstract] [Full Text] [Related]
16. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways. Liu W, Deng J, Ding W, Wang G, Shen Y, Zheng J, Zhang X, Luo Y, Lv C, Wang Y, Chen L, Yan D, Boudreau RL, Song LS, Liu J. Circ Heart Fail; 2017 Jun 24; 10(6):. PubMed ID: 28611128 [Abstract] [Full Text] [Related]